ZA794697B - Inhalation device with capsule opener - Google Patents

Inhalation device with capsule opener

Info

Publication number
ZA794697B
ZA794697B ZA00794697A ZA794697A ZA794697B ZA 794697 B ZA794697 B ZA 794697B ZA 00794697 A ZA00794697 A ZA 00794697A ZA 794697 A ZA794697 A ZA 794697A ZA 794697 B ZA794697 B ZA 794697B
Authority
ZA
South Africa
Prior art keywords
inhalation device
capsule opener
opener
capsule
inhalation
Prior art date
Application number
ZA00794697A
Other languages
English (en)
Inventor
B Poulsen
Original Assignee
Syntex Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Puerto Rico Inc filed Critical Syntex Puerto Rico Inc
Publication of ZA794697B publication Critical patent/ZA794697B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S215/00—Bottles and jars
    • Y10S215/03—Medical

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
ZA00794697A 1978-09-05 1979-09-05 Inhalation device with capsule opener ZA794697B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/939,614 US4192309A (en) 1978-09-05 1978-09-05 Inhalation device with capsule opener

Publications (1)

Publication Number Publication Date
ZA794697B true ZA794697B (en) 1981-04-29

Family

ID=25473463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00794697A ZA794697B (en) 1978-09-05 1979-09-05 Inhalation device with capsule opener

Country Status (8)

Country Link
US (1) US4192309A (fr)
BE (1) BE878603A (fr)
BR (1) BR5901187U (fr)
DE (1) DE7924612U1 (fr)
ES (1) ES245395Y (fr)
FR (1) FR2435255A1 (fr)
IT (1) IT7953540V0 (fr)
ZA (1) ZA794697B (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598053A (en) * 1978-01-31 1981-09-16 Fisons Ltd Pocket inhaler
US4262666A (en) * 1979-10-24 1981-04-21 Nelson Byron G Inhalator-breathing apparatus
JPS57500862A (fr) * 1979-10-30 1982-05-20
US4261354A (en) * 1979-11-26 1981-04-14 Nelson Byron G Inhalator-breathing apparatus
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US4655231A (en) * 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
JPS63143081A (ja) * 1986-12-05 1988-06-15 メクト株式会社 吸入器
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
US5305658A (en) * 1992-07-01 1994-04-26 Sterling Winthrop Inc. Capsule transfer device
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
FI954098A7 (fi) * 1993-03-03 1995-09-01 Tenax Corp Kuivajauheen inhalaattorin lääkeaineen kantolaite
WO1994023772A2 (fr) * 1993-04-06 1994-10-27 Minnesota Mining And Manufacturing Company Desagglomerants pour inhalateurs a poudre seche
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
MX9605717A (es) * 1994-05-18 1998-05-31 Inhale Therapeutic Syst Metodos y composiciones para la formulacion de polvo seco de interferones.
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
SE9502800D0 (sv) * 1995-08-10 1995-08-10 Astra Ab Disposable inhaler
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US20030203036A1 (en) * 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
WO2002013897A2 (fr) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalateur et procede correspondant
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
EP1483283A4 (fr) 2002-03-13 2007-04-11 Signum Biosciences Inc Modulation de la methylation de proteines et du phosphate des phosphoproteines
US20060045849A1 (en) * 2004-08-24 2006-03-02 Farhan Taghizadeh Method of customizing the fragrance of nasal medications
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
CA2601777A1 (fr) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions et procedes pour l'amelioration de la fonction cognitive
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US9345745B2 (en) 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
WO2007052154A2 (fr) 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
WO2007024876A2 (fr) * 2005-08-24 2007-03-01 The Board Of Trustees Of Leland Stanford Junior University Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
US8716220B2 (en) * 2005-09-07 2014-05-06 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
AU315527S (en) 2006-09-28 2007-08-03 Glaxo Group Ltd Inhalation device
AU2007342674B2 (en) * 2007-01-10 2013-09-19 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and uses therefor
US8496002B2 (en) * 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
JP5703466B2 (ja) * 2007-08-07 2015-04-22 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ キナーゼ阻害薬およびその使用
CA2725143A1 (fr) * 2008-05-21 2009-11-26 Neurotez, Inc. Procedes de traitement de troubles cognitifs progressifs lies a la degenerescence neurofibrillaire
CN102256613B (zh) * 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
CA2744104C (fr) * 2008-12-10 2017-07-18 Purdue Research Foundation Inhibiteur permeant cellulaire de kinases a base peptidique
EP2456772A4 (fr) 2009-07-24 2013-02-27 Amazentis Sa Composés, compositions et méthodes de protection de la santé du cerveau en cas de troubles neurodégénératifs
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
BR112013026313A8 (pt) 2011-04-12 2018-01-30 Moerae Matrix Inc composições e métodos para prevenir ou tratar doenças, condições ou processos caracterizados por proliferação anormal de fibroblastos e depósito de matriz extracelular
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
EP2701712B1 (fr) 2011-04-25 2017-06-21 Cornell University Utilisation d'uridine et de désoxyuridine pour traiter les pathologies répondant aux folates
EP2589381B1 (fr) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
WO2013134636A1 (fr) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions et procédés d'administration de peptides inhibiteurs de kinases
DK2892524T3 (da) 2012-09-04 2021-01-25 Eleison Pharmaceuticals LLC Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
KR102300576B1 (ko) 2013-09-10 2021-09-08 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 절단된 선종성 결장 폴립증 (ａｐｃ) 단백질을 타겟화하는 치료제
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
CN107106650A (zh) 2014-11-17 2017-08-29 莫伊莱麦屈克斯公司 用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法
WO2016092378A1 (fr) 2014-12-10 2016-06-16 Angelo Luigi Vescovi Procédés et compositions de réduction de la croissance, de la migration et du caractère invasif des cellules souches du cancer du cerveau, et d'amélioration de la survie de patients atteints de tumeurs du cerveau
EP3242886A4 (fr) 2015-01-08 2018-08-29 Moerae Matrix, Inc., Formulation de peptides inhibiteurs de mk2
JP2018512401A (ja) 2015-03-12 2018-05-17 モイライ マトリックス インコーポレイテッド Ｍｋ２阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用
EP3307069B1 (fr) 2015-06-10 2021-08-04 Hackensack University Medical Center Utilisation du telmisartan pour la prévention et le traitement de la maladie du greffon contre l'hôte et d'autres maladies auto-immunes et allo-immunes
CN107949279A (zh) 2015-07-06 2018-04-20 得克萨斯系统大学评议会 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
CA2991420A1 (fr) 2015-07-15 2017-01-19 The Board Of Regents Of The University Of Texas System Ciblage de proteine de liaison de l'emopamil (ebp) avec de petites molecules qui induisent une reponse de retroaction anormale par l'abaissement de la biosynthese du cholesterol endogene
AU2017210319A1 (en) 2016-01-20 2018-08-23 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
US2655259A (en) * 1949-11-15 1953-10-13 Davoren William Francis Tablet container
GB1459426A (en) * 1973-02-26 1976-12-22 Allen & Hanburys Ltd Inhalation devices
US4005711A (en) * 1975-01-13 1977-02-01 Syntex Puerto Rico, Inc. Inhalation device

Also Published As

Publication number Publication date
US4192309A (en) 1980-03-11
BR5901187U (pt) 1980-06-17
BE878603A (fr) 1980-03-05
ES245395Y (es) 1980-06-16
ES245395U (es) 1979-12-16
DE7924612U1 (de) 1979-11-29
FR2435255A1 (fr) 1980-04-04
IT7953540V0 (it) 1979-08-29

Similar Documents

Publication Publication Date Title
ZA794697B (en) Inhalation device with capsule opener
DE2960616D1 (en) Inhalation device
ZA794696B (en) Inhalation device
YU220779A (en) Inhalation device
GB2017813B (en) Closure device
IL58720A0 (en) Inhalation device
GB2024049B (en) Foamgenerating device
GB2038223B (en) Cable-cutting device
JPS5516696A (en) Breathing device
JPS54158194A (en) Piezooelectric device
GB2037715B (en) Sheet-registering device
ZA796118B (en) Inhalation device
JPS5514098A (en) Photoostimulation device
GB2025239B (en) Anaesthetic device
JPS5537690A (en) Improved electiric device
JPS5552749A (en) Ultrasoniccwave piercing device
GB2026993B (en) Crimping-on device
GB2017472B (en) Tramlining device
GB2023009B (en) Dilarion device
DE2962485D1 (en) Infusion device
DE2965793D1 (en) Quick-tightening device
GB2015043B (en) Yarnrelaxing device
JPS5574979A (en) Elevation device
JPS5519106A (en) Ultrasoniccwave diagnosts device
JPS54163258A (en) Preshifting device